Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Bamboo Works

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.06.BRIEF: Lopal Tech raises $15 million in share placement
05.06.Sainte Nutritional nurtures Hong Kong IPO
04.06.BRIEF: Vobile raises $65 million through share placement
04.06.UP Fintech gets lift from tariff-induced market volatility
04.06.BRIEF: Dobot partners with YSB on pharmacy-focused robots
04.06.BRIEF: XPeng sustains momentum in May, as Leapmotor sets new sales record
04.06.Zeekr's buyout stalls, and Chagee's returns cool
03.06.BRIEF: Ocean Park sells controlling stake in $293 million share placement
03.06.BRIEF: Lvji Tech to raise $19 million via rights issue at heavy discount
03.06.Zeekr privatization hits a speed bump
02.06.BRIEF: MetaLight bus app IPO finally stops in Hong Kong, to raise $31 million
02.06.Game time for another IPO hopeful in China's booming toy market
30.05.BRIEF: Newtrend launches Hong Kong IPO to raise up to $31 million
30.05.BRIEF: Shouhui slumps in Hong Kong trading debut
30.05.Cango's crypto makeover advances with sale of its China business
30.05.AI powers Agora back to revenue growth
30.05.BRIEF: Futu's profit doubles on stock market rebound
30.05.WeRide tries buyback maneuver in tight robotaxi race
29.05.BRIEF: Shein abandons London listing plan, heads to Hong Kong
29.05.YuHua Education's profit doubles as it bids adieu to Thailand
29.05.BRIEF: VNET loss widens even as wholesale revenue surges 86%
29.05.BRIEF: Saimo, AutoNavi to co-develop smart platform ecosystem
29.05.3SBio hits the big time with $6 billion cancer drug deal
28.05.If you don't succeed at first, second or third? FWD takes a fourth try at Hong Kong IPO
28.05.Lexin's profit jump masks slowdown in its main loan business